Cargando…
Transforaminal lumbar interbody fusion and posterior lumbar interbody fusion utilizing BMP-2 in treatment of degenerative spondylolisthesis: neither safe nor cost effective
BACKGROUND: With the rise of health care costs, there is increased emphasis on evaluating the cost of a particular surgical procedure for quality adjusted life year (QALY) gained. Recent data have shown that surgical intervention for the treatment of degenerative spondylolisthesis (DS) is as cost-ef...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642749/ https://www.ncbi.nlm.nih.gov/pubmed/23646277 http://dx.doi.org/10.4103/2152-7806.109444 |
_version_ | 1782268205975207936 |
---|---|
author | Moatz, Bradley Tortolani, P. Justin |
author_facet | Moatz, Bradley Tortolani, P. Justin |
author_sort | Moatz, Bradley |
collection | PubMed |
description | BACKGROUND: With the rise of health care costs, there is increased emphasis on evaluating the cost of a particular surgical procedure for quality adjusted life year (QALY) gained. Recent data have shown that surgical intervention for the treatment of degenerative spondylolisthesis (DS) is as cost-effective as total joint arthroplasty. Despite these excellent outcomes, some argue that the addition of interbody fusion supplemented with bone morphogenetic protein (BMP) enhances the value of this procedure. METHODS: This review examines the current research regarding the cost-effectiveness of the surgical management of lumbar DS utilizing interbody fusion along with BMP. RESULTS: Posterolateral spinal fusion with instrumentation for focal lumbar spinal stenosis with DS can provide and maintain improvement in self-reported quality of life. Based on the available literature, including nonrandomized comparative studies and case series, the addition of interbody fusion along with BMP does not lead to significantly better clinical outcomes and increases costs when compared with more routine posterolateral fusion techniques. CONCLUSIONS: To enhance the value of the surgical management for DS, costs must decrease or there should be substantial improvement in effectiveness as measured by clinical outcomes. To date, there is insufficient evidence to support the use of interbody fusion devices along with BMP to treat routine cases of focal stenosis accompanied by DS, which are routinely adequately treated utilizing posterolateral fusion techniques. |
format | Online Article Text |
id | pubmed-3642749 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-36427492013-05-03 Transforaminal lumbar interbody fusion and posterior lumbar interbody fusion utilizing BMP-2 in treatment of degenerative spondylolisthesis: neither safe nor cost effective Moatz, Bradley Tortolani, P. Justin Surg Neurol Int Surgical Neurology International: Spine BACKGROUND: With the rise of health care costs, there is increased emphasis on evaluating the cost of a particular surgical procedure for quality adjusted life year (QALY) gained. Recent data have shown that surgical intervention for the treatment of degenerative spondylolisthesis (DS) is as cost-effective as total joint arthroplasty. Despite these excellent outcomes, some argue that the addition of interbody fusion supplemented with bone morphogenetic protein (BMP) enhances the value of this procedure. METHODS: This review examines the current research regarding the cost-effectiveness of the surgical management of lumbar DS utilizing interbody fusion along with BMP. RESULTS: Posterolateral spinal fusion with instrumentation for focal lumbar spinal stenosis with DS can provide and maintain improvement in self-reported quality of life. Based on the available literature, including nonrandomized comparative studies and case series, the addition of interbody fusion along with BMP does not lead to significantly better clinical outcomes and increases costs when compared with more routine posterolateral fusion techniques. CONCLUSIONS: To enhance the value of the surgical management for DS, costs must decrease or there should be substantial improvement in effectiveness as measured by clinical outcomes. To date, there is insufficient evidence to support the use of interbody fusion devices along with BMP to treat routine cases of focal stenosis accompanied by DS, which are routinely adequately treated utilizing posterolateral fusion techniques. Medknow Publications & Media Pvt Ltd 2013-03-22 /pmc/articles/PMC3642749/ /pubmed/23646277 http://dx.doi.org/10.4103/2152-7806.109444 Text en Copyright: © 2013 Moatz B http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Surgical Neurology International: Spine Moatz, Bradley Tortolani, P. Justin Transforaminal lumbar interbody fusion and posterior lumbar interbody fusion utilizing BMP-2 in treatment of degenerative spondylolisthesis: neither safe nor cost effective |
title | Transforaminal lumbar interbody fusion and posterior lumbar interbody fusion utilizing BMP-2 in treatment of degenerative spondylolisthesis: neither safe nor cost effective |
title_full | Transforaminal lumbar interbody fusion and posterior lumbar interbody fusion utilizing BMP-2 in treatment of degenerative spondylolisthesis: neither safe nor cost effective |
title_fullStr | Transforaminal lumbar interbody fusion and posterior lumbar interbody fusion utilizing BMP-2 in treatment of degenerative spondylolisthesis: neither safe nor cost effective |
title_full_unstemmed | Transforaminal lumbar interbody fusion and posterior lumbar interbody fusion utilizing BMP-2 in treatment of degenerative spondylolisthesis: neither safe nor cost effective |
title_short | Transforaminal lumbar interbody fusion and posterior lumbar interbody fusion utilizing BMP-2 in treatment of degenerative spondylolisthesis: neither safe nor cost effective |
title_sort | transforaminal lumbar interbody fusion and posterior lumbar interbody fusion utilizing bmp-2 in treatment of degenerative spondylolisthesis: neither safe nor cost effective |
topic | Surgical Neurology International: Spine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642749/ https://www.ncbi.nlm.nih.gov/pubmed/23646277 http://dx.doi.org/10.4103/2152-7806.109444 |
work_keys_str_mv | AT moatzbradley transforaminallumbarinterbodyfusionandposteriorlumbarinterbodyfusionutilizingbmp2intreatmentofdegenerativespondylolisthesisneithersafenorcosteffective AT tortolanipjustin transforaminallumbarinterbodyfusionandposteriorlumbarinterbodyfusionutilizingbmp2intreatmentofdegenerativespondylolisthesisneithersafenorcosteffective |